Brief: Impel Neuropharma Reports $1.24 Q3 Loss Per Share

IPI Legacy Liquidation Co

15/11/2021 13:17

Nov 15 (Reuters) - Impel Neuropharma Inc  IMPL.O :
    * IMPEL NEUROPHARMA ANNOUNCES THIRD QUARTER 2021 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
    * Q3 NON-GAAP LOSS PER SHARE $1.23
    * Q3 GAAP LOSS PER SHARE $1.24
    * INCREASED CASH POSITION AND EXTENDED RUNWAY INTO 2023 WITH
FOLLOW-ON EQUITY OFFERING OF 3.45 MILLION SHARES VALUED AT $51.8
MILLION

Source text for Eikon:  ID:nGNX2ZvhQy 
Further company coverage:  IMPL.O 

 ((Reuters.Briefs@thomsonreuters.com;))